A child sits on an examination table while a doctor examines their feet. Maize block M followed by C.S. Mott Children's Hospital, University of Michigan Health

Pediatric Rheumatology (Autoimmune Diseases)

Pediatric rheumatologists use advanced testing and specialized expertise to diagnose, treat and manage autoimmune and inflammatory conditions that affect a child's joints, muscles, bones and internal organs.

Your Michigan Answer for Pediatric Autoimmune & Inflammatory Conditions

When your child is facing joint pain, muscle weakness or a rare autoimmune or inflammatory condition, where you seek care makes all the difference. At U-M Health C.S. Mott Children's Hospital, our pediatric rheumatology experts care for children with even the rarest autoimmune and inflammatory disorders. We offer specialized programs for conditions such as juvenile lupus, juvenile dermatomyositis, scleroderma, vasculitis, and other complex rheumatic diseases.

Every child’s condition is unique, which means their care needs to be, too. That’s why our team works with specialists across pediatrics to build a personalized treatment plan tailored to your child’s symptoms, growth, development, and long-term health needs. With advanced diagnostic tools, onsite pediatric laboratory services, imaging designed specifically for children, and access to the newest treatment approaches, we provide the most comprehensive care available for young patients.

If your child is living with an autoimmune or inflammatory condition, C.S. Mott Children's Hospital offers the expertise, support and answers your family can rely on.

Looking for a Doctor or Location?

Find a Pediatric Rheumatologist

Pediatric Rheumatology Locations

Give to Pediatric Rheumatology

Your gift to Pediatric Rheumatology helps us provide the care children need for improved quality of life and healthier futures.

News & Stories

 scratching arm pink sweater in living room teal couch
Health Lab

A metabolic “switch” that could help reset scar-producing cells in scleroderma

Researchers at University of Michigan Health and collaborating institutions have identified a metabolic enzyme that may offer a fundamentally new way to attack one of the most difficult-to-treat features of systemic sclerosis, or scleroderma: progressive and potentially life threatening tissue scarring.
 graphic of red green orange blue close up of inside of body and insides shaking
Health Lab

Pain, psychological factors and physical function closely linked in people with systemic sclerosis

For many people living with chronic conditions like systemic sclerosis, pain can be persistent, unpredictable, and difficult to manage leading to a strong impact on a patient’s mental health.
 woman in michigan sweatshirt zipped up holding tomato smiling with hat on in green farm
Health Lab

Rheumatologist finds contentment and community through family farm

A U-M rheumatologist finds contentment and community through family farming.
 woman itching skin orange blue button down
Health Lab

A first-of-its-kind treatment for mastocytosis

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.
 women looking at model hand in front of poster and computer on table next to them
Health Lab

Rethinking how clinicians learn to feel disease

For most doctors, learning to recognize swollen joints begins in the classroom. A clinical assistant professor in Michigan Medicine's Division of Rheumatology saw a gap in how to distinguish subtle swelling in joints, thus creating a hand simulator to help.
 woman taking her blood pressure on bed while pregnant
Health Lab

Researchers discover what may be the root cause of preeclampsia, and how to fix it

After years of research, a large team of multidisciplinary scientists from Michigan Medicine has identified a key molecular driver of preeclampsia, and demonstrated a potential way to counteract it in both mouse models and human placental tissue.